caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1730136862

Angeles Lai ZayasM.D.

Internal MedicinePasadena, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
590
Unique beneficiaries
—
Total services
1,119
Distinct HCPCS
10
Medicare payment
$61K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 6,183 Internal Medicine providers in TX — above median (cohort median 673).
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
100.0
Cost
83.7
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.05%
Individual
REFERRAL NETWORK

Where Angeles Lai Zayas's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
165526
CHCA BAYSHORE LP91417
PMC HOSPITAL, LLC38141
KIDWELL, MONA36114
Tariq Hashmy
Diagnostic Radiology · Houston, TX
36100
James Tran
Internal Medicine · Pasadena, TX
26240
Dixie Melillo
General Surgery · Pasadena, TX
2436
Gerhard Wittich
Diagnostic Radiology · Houston, TX
1567
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
1549
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$41
Payment records
2
By payment type
Food and Beverage$41
PRESCRIBING · PART D · 2024
Total Rx claims
12,992
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
158
Brand share
20.5%
Top prescribed drugs
Atorvastatin Calcium799 claims
Levothyroxine Sodium778 claims
Amlodipine Besylate564 claims
Losartan Potassium481 claims
Omeprazole415 claims